FDA panel approves Gardasil HPV vaccine for males, and competing Cervarix might hit shelves soon

September 10, 2009

Vaccines for the human papillomavirus (HPV) might not be just for girls anymore. A medical advisory panel for the U.S. Food and Drug Administration (FDA) voted today that the use of Gardasil to prevent HPV, a sexually transmitted disease, in males ages 9 to 26 would be both safe and effective. (Scientific American)